Management of patients with allergic rhinitis and asthma: Literature review

Southern Medical Journal

Volumn 102, Issue 9, 2009, Pages 935-941

  Nathan, Robert A ^a  

^a Asthma and Allergy Associates and Research Center   (United States)

Author keywords

Allergic rhinitis; Antihistamines; Antileukotrienes; Asthma histamine H 1 antagonists

Indexed keywords

ANTIHISTAMINIC AGENT; BECLOMETASONE; BUDESONIDE; CETIRIZINE; DECONGESTIVE AGENT; DESLORATADINE; FLUNISOLIDE; FLUTICASONE; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; GLUCOCORTICOID; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LEVOCETIRIZINE; LORATADINE; MOMETASONE FUROATE; MONTELUKAST; OMALIZUMAB; PSEUDOEPHEDRINE; SALBUTAMOL;

ALLERGIC RHINITIS; ASTHMA; CLINICAL TRIAL; COMORBIDITY; DIAGNOSTIC APPROACH ROUTE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; HAY FEVER; HUMAN; IMMUNOTHERAPY; LOWER RESPIRATORY TRACT; MEDICAL DECISION MAKING; PERENNIAL RHINITIS; QUALITY OF LIFE; RESPIRATORY TRACT MUCOSA; REVIEW; SYMPTOMATOLOGY; TREATMENT INDICATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; UPPER RESPIRATORY TRACT;

ANTI-ALLERGIC AGENTS; ANTIBODIES, MONOCLONAL; ASTHMA; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; IMMUNIZATION, PASSIVE; LEUKOTRIENE ANTAGONISTS; RHINITIS, ALLERGIC, PERENNIAL; STEROIDS;

EID: 70349115261     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3181b01c68     Document Type: Review

References (42)

1. Gaugris S, Sazonov-Kocevar V, Thomas M. Burden of concomitant allergic rhinitis in adults with asthma. J Asthma 2006;43:1-7.
2. Bachert C, van Cauwenberge P, Khaltaev N; World Health Organization. Allergic rhinitis and its impact on asthma. In collaboration with the World Health Organization. Executive summary of the workshop report. 7-10 December 1999, Geneva, Switzerland. Allergy 2002;57:841-855.
3. Bousquet J, Van Cauwenberge P, Khaltaev N; ARIA Workshop Group; World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 2001;108(suppl 5):S147-S334.
4. Global strategy for asthma management and prevention. Global Initiative for Asthma (GINA). Available at: http://www.ginasthma.com/ Guidelineitem.asp?l1- 2&l2-1&intId-60. Accessed September 16, 2008.
5. Bloom B, Cohen RA. Summary health statistics for U.S. children: National Health Interview Survey, 2006. Vital Health Stat 10 2007; 234:1-79.
6. Pleis JR, Lethbridge-Cejku M. Summary health statistics for U.S. adults: National Health Interview Survey, 2006. Vital Health Stat 10 2007;235: 1-153.
7. Meng YY, Babey SH, Hastert TA, et al. Uncontrolled asthma means missed work and school, emergency department visits for many Californians. Policy Brief UCLA Cent Health Policy Res 2008;PB2008-2:1-8.
8. Guerra S, Sherrill DL, Martinez FD, et al. Rhinitis as an independent risk factor for adult-onset asthma. J Allergy Clin Immunol 2002;109:419-425.
9. Navarro A, Valero A, Juliá B, et al. Coexistence of asthma and allergic rhinitis in adult patients attending allergy clinics: ONEAIR study. J Investig Allergol Clin Immunol 2008;18:233-238.
10. Leynaert B, Neukirch F, Demoly P, et al. Epidemiologic evidence for asthma and rhinitis comorbidity. J Allergy Clin Immunol 2000;106:S201-S205.
11. Rusconi F, Galassi C, Corbo GM, et al. Risk factors for early, persistent, and late-onset wheezing in young children. SIDRIA Collaborative Group. Am J Respir Crit Care Med 1999;160(5 pt 1):1617-1622.
12. Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet 2008;372:1049-1057.
13. Settipane RJ, Hagy GW, Settipane GA. Long-term risk factors for developing asthma and allergic rhinitis: a 23-year follow-up study of college students. Allergy Proc 1994;15:21-25.
14. Halpern MT, Schmier JK, Richner R, et al. Allergic rhinitis: a potential cause of increased asthma medication use, costs, and morbidity. J Asthma 2004;41:117-126.
15. Magnan A, Meunier JP, Saugnac C, et al. Frequency and impact of allergic rhinitis in asthma patients in everyday general medical practice: a French observational cross-sectional study. Allergy 2008;63:292-298.
16. Bousquet J, Vignola AM, Demoly P. Links between rhinitis and asthma. Allergy 2003;58:691-706.
17. Jeffery PK, Haahtela T. Allergic rhinitis and asthma: inflammation in a one-airway condition. BMC Pulm Med 2006;6(suppl 1):S5.
18. Humbles AA, Lloyd CM, McMillan SJ, et al. A critical role for eosin-ophils in allergic airways remodeling. Science 2004;305:1776-1779.
19. Saglani S, Malmström K, Pelkonen AS, et al. Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med 2005;171:722-727.
20. Meltzer EO. The relationships of rhinitis and asthma. Allergy Asthma Proc 2005;26:336-340.
21. Ciprandi G, Cirillo I, Vizzaccaro A, et al. Early bronchial airflow impairment in patients with persistent allergic rhinitis and bronchial hy-perreactivity. Respir Med 2005;99:1606-1612.
22. Ciprandi G, Cirillo I, Pistorio A, et al. Impact of allergic rhinitis on asthma: effects on bronchodilation testing. Ann Allergy Asthma Immunol 2008;101:42-46.
23. Crystal-Peters J, Neslusan C, Crown WH, et al. Treating allergic rhinitis in patients with comorbid asthma: the risk of asthma-related hospitalizations and emergency department visits. J Allergy Clin Immunol 2002; 109:57-62.
24. Grant JA, Nicodemus CF, Findlay SR, et al. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol 1995;95:923-932.
25. Baena-Cagnani CE, Berger WE, DuBuske LM, et al. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma. Int Arch Allergy Immunol 2003;130:307-313.
26. Pasquali M, Baiardini I, Rogkakou A, et al. Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters. Clin Exp Allergy 2006;36:1161-1167.
27. Bachert C, Bousquet J, Canonica GW, et al. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol 2004;114:838-844.
28. Bachert C, Demarteau N. Levocetirizine reduces asthma comorbidity in patients with persistent allergic rhinitis: An exploratory analysis of the XPERT trial [abstract 238]. J World Allergy Org 2005;1:100-101.
29. Corren J, Harris AG, Aaronson D, et al. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. J Allergy Clin Immunol 1997;100:781-788.
30. Nathan RA, Finn AF Jr, LaForce C, et al. Comparison of cetirizine-pseudoephedrine and placebo in patients with seasonal allergic rhinitis and concomitant mild-to-moderate asthma: randomized, double-blind study. Ann Allergy Asthma Immunol 2006;97:389-396.
31. Nathan RA, Kemp JP; Antileukotriene Working Group. Efficacy of antileukotriene agents in asthma management. Ann Allergy Asthma Im-munol 2001;86:9-17.
32. Philip G, Nayak AS, Berger WE, et al. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin 2004;20:1549-1558.
33. Busse WW, Casale TB, Dykewicz MS, et al. Efficacy of montelukast during the allergy season in patients with chronic asthma and seasonal aeroallergen sensitivity. Ann Allergy Asthma Immunol 2006;96:60-68.
34. Bousquet J, van Cauwenberge P, Ait Khaled N, et al; GA2LEN. Pharmacologic and anti-IgE treatment of allergic rhinitis ARIA update (in collaboration with GA2LEN). Allergy 2006;61:1086-1096.
35. Adams RJ, Fuhlbrigge AL, Finkelstein JA, et al. Intranasal steroids and the risk of emergency department visits for asthma. J Allergy Clin Im-munol 2002;109:636-642.
36. Nathan RA, Yancey SW, Waitkus-Edwards K, et al. Fluticasone propi-onate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control. Chest 2005;128:1910-1920.
37. Casale TB, Condemi J, LaForce C, et al; Omalizumab Seasonal Allergic Rhinitis Trail Group. Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial. JAMA 2001;286:2956-2967.
38. Vignola AM, Humbert M, Bousquet J, et al. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR. Allergy 2004;59:709-717.
39. Jacobsen L, Nuchel Petersen B, Wihl JA, et al. Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from long-term (6-year) follow-up. Allergy 1997;52:914-920.
40. Jacobsen L, Niggemann B, Dreborg S, et al; The PAT Investigator Group. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy 2007;62:943-948.
41. Kopp MV, Hamelmann E, Zielen S, et al; DUAL Study Group. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjuncti-vitis and co-morbid seasonal allergic asthma. Clin Exp Allergy 2009; 39:271-279.
42. Bousquet J, Khaltaev N, Cruz AA, et al; World Health Organization; GA(2)LEN; AllerGen. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 2008;63(suppl 86):8-160.